Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
Pfizer
M.D. Anderson Cancer Center
Stanford University
Erasca, Inc.
Jonsson Comprehensive Cancer Center
Degron Therapeutics Co.
Actym Therapeutics, Inc.
Ikena Oncology
Eli Lilly and Company
Columbia University
Thomas Jefferson University
Theratechnologies
National Cancer Institute (NCI)
ABM Therapeutics Corporation
National Cancer Institute (NCI)
MacroGenics
Fore Biotherapeutics
Celgene
Celgene
University of Chicago
Calando Pharmaceuticals
Rutgers, The State University of New Jersey
Mannkind Corporation